Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Colistin Atc J01Xb01 Obg For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6340118

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Medicines Containing The Active Substance Ustekinumab Atc L04Ac05

Deadline: 31 May 2026

Germany

Ref. No.: 6337480

EMD:Ref Document

Bid Value: Ref Document

-3 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Albendazole Atc P02Ca03 Obg For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6337365

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Pomalidomide Atc L04Ax06 Obg For The Period 01 08 2024 31 07 2026

Deadline: 05 Jun 2026

Germany

Ref. No.: 6335525

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Open House Drug Rebate Agreements Dolutegravir And Rilpivirine Atc J05Ar21

Deadline: 05 Jun 2026

Germany

Ref. No.: 6330837

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Construction Of A Teaching Pool At The Schilksee Swimming Pool Structural Planning

Deadline: 28 Feb 2027

Germany

Ref. No.: 6330771

EMD:Ref Document

Bid Value: Ref Document

270 Days Left

Open House Drug Rebate Agreements Pazopanib Atc L01Ex03

Deadline: 05 Jun 2026

Germany

Ref. No.: 6330518

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Open House Drug Discount Agreements Pimecrolimus Atc D11Ah02

Deadline: 05 Jun 2026

Germany

Ref. No.: 6329785

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Conclusion Of A Non Exclusive Discount Agreement According To Section 130A Paragraph 8 Sgb V For The Active Ingredient Lisdexamfetamine Atc N06Ba12 Obg For The Period 01 08 24 31 07 25 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6322269

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Medicines Containing The Active Ingredient Lanthanum Iii Carbonate Atc V03Ae03 In The Dosage Form Chewable Tablets

Deadline: 31 May 2026

Germany

Ref. No.: 6321582

EMD:Ref Document

Bid Value: Ref Document

-3 Days Left

The Provision Of Specialist Substance Use Detoxification And Rehabilitation Services Lcc37252

Deadline: 31 Jul 2034

Great Britain

Ref. No.: 6321422

EMD:Ref Document

Bid Value: Ref Document

2980 Days Left

Innovative Platform For Home Based Services

Deadline: 17 May 2043

Great Britain

Ref. No.: 6321406

EMD:Ref Document

Bid Value: Ref Document

6192 Days Left

Conclusion Of Non Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredients Mentioned With The Possibility Of Conclusion Within The Framework Of The So Called Open House Procedure

Deadline: 31 Dec 2026

Germany

Ref. No.: 6321334

EMD:Ref Document

Bid Value: Ref Document

211 Days Left

Conclusion Of A Non Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Sgb V For The Active Ingredient Omalizumab Atc R03Dx05 Obo For The Period 01 08 2024 31 07 2025 Plus Extension Option 1X12 Months

Deadline: 05 Jun 2026

Germany

Ref. No.: 6320404

EMD:Ref Document

Bid Value: Ref Document

2 Days Left

Orthotic Services

Deadline: 16 Jun 2027

Canada

Ref. No.: 6320192

EMD:Ref Document

Bid Value: Ref Document

378 Days Left

Filter Your Search

Tenders by Countries

Browse Popular Sectors

Projects by Regions

Funding Agency

Support

CONTACT DETAILS

Filter Your Search

FREE Trial plan for all new users!